“Open-mouth breathing is also linked to sleep disorders like obstructive sleep apnea since the airway is being less ...

What a session it was for a certain Colorado-based %Healthcare company after it was announced that it received the US Food ...

Vivos Therapeutics is a pioneering medical device and technology company focused on addressing sleep-related breathing disorders (SRBDs), particularly obstructive sleep apnea (OSA). Their flagship ...

ResMed (RMD) stock falls as Wolfe downgrades due to potential label expansion for Eli Lilly's (LLY) tirzepatide in ...

Vivos Therapeutics (VVOS) stock gains as company receives FDA clearance for its DNA appliance to treat obstructive sleep ...

Vivos Therapeutics (NASDAQ: VVOS), a leading medical-device and technology company specializing in the development and commercialization of highly effective proprietary treatments for sleep-related ...

The FDA has granted 510(k) clearance to Vivos Therapeutics' DNA oral appliance for treating moderate to severe obstructive ...

said this is believed to be the first ever FDA clearance to treat moderate to severe obstructive sleep apnea and snoring in children. The 510(k) clearance allows medical devices to enter the U.S.

Vivos is poised to disrupt the very significant pediatric obstructive sleep apnea (OSA) market with new FDA clearance and new strategic marketing ...

(RTTNews) - Vivos Therapeutics, Inc. (VVOS) announced on Wednesday that it has obtained 510(k) clearance from the FDA for its DNA oral medical device aimed at treating moderate to severe obstructive ...